Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Farmers Insurance
Argus Health
Moodys
McKesson
Colorcon

Generated: August 18, 2019

DrugPatentWatch Database Preview

Patent: 6,462,017

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,462,017
Title: Method of reducing side effects of chemotherapy in cancer patients
Abstract:A method for reducing the severity of chemotherapy side effects in cancer patients by administering thymosin .alpha..sub.1 in conjunction with the administration of a chemotherapy agent to the patient. As a result of the reduction of post-chemotherapy side effects, patients experience an increase in the quality of life.
Inventor(s): Rudolph; Alfred R. (Los Altos Hills, CA), Tam; Vincent Chung-Ying (Hong Kong, HK), Quan; Maggie Jie (Shanghai, CN)
Assignee: SciClone Pharmaceuticals, Inc. (San Mateo, CA)
Application Number:09/561,917
Patent Claims:see list of patent claims

Details for Patent 6,462,017

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25 ➤ Sign Up SciClone Pharmaceuticals, Inc. (San Mateo, CA) 2036-04-30 RX Orphan search
Eisai Inc ONTAK denileukin diftitox VIAL 103767 001 1999-02-05 ➤ Sign Up SciClone Pharmaceuticals, Inc. (San Mateo, CA) 2036-04-30 RX Orphan search
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Sign Up SciClone Pharmaceuticals, Inc. (San Mateo, CA) 2036-04-30 RX search
Berlex Labs LEUKINE sargramostim VIAL 103362 002 1991-03-05 ➤ Sign Up SciClone Pharmaceuticals, Inc. (San Mateo, CA) 2036-04-30 RX search
Berlex Labs LEUKINE sargramostim VIAL 103362 001 1991-03-05 ➤ Sign Up SciClone Pharmaceuticals, Inc. (San Mateo, CA) 2036-04-30 RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Mallinckrodt
Covington
Julphar
Johnson and Johnson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.